Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melatonin Versus Placebo for Bipolar Disorder - a Double Blinded Randomised Controlled Trial

NCT07472075 is registered in ClinicalTrials.gov with Lars Vedel Kessing as lead sponsor.

NCT NCT07472075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07472075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melatonin Versus Placebo for Bipolar Disorder - a Double Blinded Randomised Controlled Trial
Lead sponsor
Lars Vedel Kessing
Phase
Phase 2
Overall status
Recruiting
Start date
May 8, 2026
Completion date
June 30, 2028
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar affective disorder